145 related articles for article (PubMed ID: 16313237)
21. A novel assay for factor XIII based on cross-linking of synthetic peptides: analysis of different substrates.
Kusch M; Grundmann C; Keitel S; Seitz R; König H
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):575-80. PubMed ID: 16988554
[TBL] [Abstract][Full Text] [Related]
22. [Changes of factor XIII a and b subunit in patients with disseminated intravascular coagulation syndrome].
Sugimura D; Fukue H; Arai M; Matsumoto K; Fukutake K
Rinsho Byori; 1996 Apr; 44(4):355-61. PubMed ID: 8847818
[TBL] [Abstract][Full Text] [Related]
23. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics.
Nielsen VG; Kirklin JK; Hoogendoorn H; Ellis TC; Holman WL
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):145-50. PubMed ID: 17287631
[TBL] [Abstract][Full Text] [Related]
24. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
Hellstern P; Schilz K; von Blohn G; Wenzel E
Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
[TBL] [Abstract][Full Text] [Related]
25. High-throughput scintillation proximity assay for transglutaminase activity measurement.
Mádi A; Kárpáti L; Kovács A; Muszbek L; Fésüs L
Anal Biochem; 2005 Aug; 343(2):256-62. PubMed ID: 15992758
[TBL] [Abstract][Full Text] [Related]
26. A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears.
Orosz ZZ; Katona E; Facskó A; Berta A; Muszbek L
J Immunol Methods; 2010 Feb; 353(1-2):87-92. PubMed ID: 20079358
[TBL] [Abstract][Full Text] [Related]
27. Factor XIII Deficiency.
Karimi M; Bereczky Z; Cohan N; Muszbek L
Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
[TBL] [Abstract][Full Text] [Related]
28. [Condition setting for the measurement of blood coagulation factor XIII activity using a fully automated blood coagulation analyzer, COAGTRON-350].
Kanno N; Kaneko M; Tanabe K; Jyona M; Yokota H; Yatomi Y
Rinsho Byori; 2012 Dec; 60(12):1131-8. PubMed ID: 23427694
[TBL] [Abstract][Full Text] [Related]
29. Identification of new amine acceptor protein substrate candidates of transglutaminase in rat liver extract: use of 5-(biotinamido) pentylamine as a probe.
Ichikawa A; Ishizaki J; Morita M; Tanaka K; Ikura K
Biosci Biotechnol Biochem; 2008 Apr; 72(4):1056-62. PubMed ID: 18391459
[TBL] [Abstract][Full Text] [Related]
30. In vitro modification of betaine-homocysteine S-methyltransferase by tissue-type transglutaminase.
Ichikawa A; Ohashi Y; Terada S; Natsuka S; Ikura K
Int J Biochem Cell Biol; 2004 Oct; 36(10):1981-92. PubMed ID: 15203112
[TBL] [Abstract][Full Text] [Related]
31. Three different cell types can synthesize factor XIII subunit A in the human liver.
Adány R; Antal M
Thromb Haemost; 1996 Jul; 76(1):74-9. PubMed ID: 8819255
[TBL] [Abstract][Full Text] [Related]
32. A microassay for measuring glycogen in 96-well-cultured cells.
Gómez-Lechón MJ; Ponsoda X; Castell JV
Anal Biochem; 1996 May; 236(2):296-301. PubMed ID: 8660508
[TBL] [Abstract][Full Text] [Related]
33. Preclinical safety and pharmacokinetics of recombinant human factor XIII.
Ponce RA; Visich JE; Heffernan JK; Lewis KB; Pederson S; Lebel E; Andrews-Jones L; Elliott G; Palmer TE; Rogge MC
Toxicol Pathol; 2005; 33(4):495-506. PubMed ID: 16036868
[TBL] [Abstract][Full Text] [Related]
34. A fluorescent substrate of transglutaminase for detection and characterization of glutamine acceptor compounds.
Pasternack R; Laurent HP; Rüth T; Kaiser A; Schön N; Fuchsbauer HL
Anal Biochem; 1997 Jun; 249(1):54-60. PubMed ID: 9193708
[TBL] [Abstract][Full Text] [Related]
35. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
[TBL] [Abstract][Full Text] [Related]
36. Validated sandwich ELISA for the quantification of tissue transglutaminase in tissue homogenates and cell lysates of multiple species.
Brevé JJ; Drukarch B; van Strien M; van Dam AM
J Immunol Methods; 2008 Mar; 332(1-2):142-50. PubMed ID: 18279887
[TBL] [Abstract][Full Text] [Related]
37. Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Bereczky Z; Balogh E; Katona E; Czuriga I; Kárpáti L; Shemirani AH; Edes I; Muszbek L
Thromb Res; 2008; 121(4):469-76. PubMed ID: 17597187
[TBL] [Abstract][Full Text] [Related]
38. Comparative characterization of direct and indirect substrate probes for on-chip transamidating activity assay of transglutaminases.
Lee K; Jung SH; Kong DH; Hwang BM; Han ET; Park SW; Park JH; Kim YM; Ha KS
J Biotechnol; 2013 Dec; 168(4):324-30. PubMed ID: 24140601
[TBL] [Abstract][Full Text] [Related]
39. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents.
Frost GI; Stern R
Anal Biochem; 1997 Sep; 251(2):263-9. PubMed ID: 9299025
[TBL] [Abstract][Full Text] [Related]
40. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
